BENJAMIN C CREELAN

Allopathic & Osteopathic Physicians|Internal Medicine TAMPA, FL NPI 1326257262

General Payments — all program years on this page

$205,948.19

Category: General Payments
Program years: PY2018–2024
Record count: 218
As of (CMS publication): 2026-01-23

Latest program year (PY2024): $34,808.84 across 42 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of payment	Amount	Records
Consulting Fee	$18,807.50	7
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$12,160.00	8
Travel and Lodging	$2,609.11	13
Food and Beverage	$1,232.23	14

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entity	Amount	Records
Acerta Pharma LLC	$12,781.31	15
Iovance Biotherapeutics, Inc.	$7,749.19	10
Boehringer Ingelheim Pharmaceuticals, Inc.	$6,660.00	2
ABBVIE INC.	$2,550.78	3
Regeneron Healthcare Solutions, Inc.	$2,254.16	4
Janssen Biotech, Inc.	$1,725.00	1
Regeneron Pharmaceuticals, Inc.	$1,052.18	6
Merck Sharp & Dohme Corporation	$36.22	1

By program year

Program year	Amount	Records
2018	$32,558.40	43
2019	$28,169.24	31
2020	$21,207.59	20
2021	$23,350.49	22
2022	$27,173.44	26
2023	$38,680.19	34
2024	$34,808.84	42

Records — PY2024 (42)

Record ID	Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Source
1078495445	Janssen Biotech, Inc.	$1,725.00	08/16/2024	Consulting Fee	Undisputed	01/23/2026	View at CMS
1103133179	ABBVIE INC.	$2,175.00	09/23/2024	Consulting Fee	Undisputed	01/23/2026	View at CMS
1103514420	ABBVIE INC.	$50.00	09/07/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104182224	ABBVIE INC.	$325.78	10/23/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1104362083	AstraZeneca Pharmaceuticals LP	$3,200.00	06/24/2024	Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	Undisputed	01/23/2026	View at CMS
1104597202	AstraZeneca Pharmaceuticals LP	$99.46	08/08/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104601352	AstraZeneca Pharmaceuticals LP	$2,560.00	11/11/2024	Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	Undisputed	01/23/2026	View at CMS
1104778370	AstraZeneca Pharmaceuticals LP	$48.24	06/18/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1104781648	AstraZeneca Pharmaceuticals LP	$300.00	05/07/2024	Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	Undisputed	01/23/2026	View at CMS
1105290845	AstraZeneca Pharmaceuticals LP	$250.00	10/20/2024	Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	Undisputed	01/23/2026	View at CMS
1105304255	AstraZeneca Pharmaceuticals LP	$250.00	10/15/2024	Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	Undisputed	01/23/2026	View at CMS
1105346794	AstraZeneca Pharmaceuticals LP	$3,200.00	08/26/2024	Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	Undisputed	01/23/2026	View at CMS
1105393314	AstraZeneca Pharmaceuticals LP	$79.16	06/18/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1105519209	AstraZeneca Pharmaceuticals LP	$119.37	04/04/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1105676541	AstraZeneca Pharmaceuticals LP	$250.00	09/24/2024	Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	Undisputed	01/23/2026	View at CMS
1105701340	AstraZeneca Pharmaceuticals LP	$114.78	11/06/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1105714970	AstraZeneca Pharmaceuticals LP	$2,150.00	04/08/2024	Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	Undisputed	01/23/2026	View at CMS
1105715152	AstraZeneca Pharmaceuticals LP	$100.00	08/08/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1105865094	AstraZeneca Pharmaceuticals LP	$60.30	08/08/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1114031017	Regeneron Healthcare Solutions, Inc.	$297.50	04/12/2024	Consulting Fee	Undisputed	01/23/2026	View at CMS
1114031019	Regeneron Healthcare Solutions, Inc.	$1,785.00	04/12/2024	Consulting Fee	Undisputed	01/23/2026	View at CMS
1114031021	Regeneron Healthcare Solutions, Inc.	$108.42	06/02/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1114031023	Regeneron Healthcare Solutions, Inc.	$63.24	09/08/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1114397779	Regeneron Pharmaceuticals, Inc.	$386.54	10/28/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1114397781	Regeneron Pharmaceuticals, Inc.	$35.25	10/28/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1114397783	Regeneron Pharmaceuticals, Inc.	$146.59	11/15/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1114397785	Regeneron Pharmaceuticals, Inc.	$214.25	11/18/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1114397787	Regeneron Pharmaceuticals, Inc.	$47.88	11/20/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1114397789	Regeneron Pharmaceuticals, Inc.	$221.67	11/27/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1117964919	Boehringer Ingelheim Pharmaceuticals, Inc.	$2,220.00	12/16/2024	Consulting Fee	Undisputed	01/23/2026	View at CMS
1117964921	Boehringer Ingelheim Pharmaceuticals, Inc.	$4,440.00	08/19/2024	Consulting Fee	Undisputed	01/23/2026	View at CMS
1141684471	Merck Sharp & Dohme LLC	$36.22	09/09/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1147112768	Iovance Biotherapeutics, Inc.	$6,165.00	12/10/2024	Consulting Fee	Undisputed	01/23/2026	View at CMS
1147112780	Iovance Biotherapeutics, Inc.	$834.89	09/17/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1147112784	Iovance Biotherapeutics, Inc.	$34.96	09/25/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1147112812	Iovance Biotherapeutics, Inc.	$61.78	10/01/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1147112816	Iovance Biotherapeutics, Inc.	$53.38	10/01/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1147112828	Iovance Biotherapeutics, Inc.	$159.76	10/01/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1147112832	Iovance Biotherapeutics, Inc.	$79.83	10/02/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1147112852	Iovance Biotherapeutics, Inc.	$159.76	10/04/2024	Travel and Lodging	Undisputed	01/23/2026	View at CMS
1147112856	Iovance Biotherapeutics, Inc.	$63.63	10/13/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1147112868	Iovance Biotherapeutics, Inc.	$136.20	10/17/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS

Provenance & corrections

Dataset: CMS Open Payments — General Payments
Source: CMS Open Payments dataset (bulk file)
Publisher of source data: Centers for Medicare & Medicaid Services
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.